Sodium hydride → HCID 68549442, compound
Reaction equation
Br[C:2]1[N:3]([CH2:10][C:11]([CH3:28])([OH:27])[CH2:12][N:13]2[CH2:19][CH2:18][CH2:17][N:16]([C:20]3[N:25]=[CH:24][C:23]([Br:26])=[CH:22][N:21]=3)[CH2:15][CH2:14]2)[CH:4]=[C:5]([N+:7]([O-:9])=[O:8])[N:6]=1.[H-].[Na+]>CN(C=O)C.[NH4+].[Cl-]>[Br:26][C:23]1[CH:22]=[N:21][C:20]([N:16]2[CH2:17][CH2:18][CH2:19][N:13]([CH2:12][C:11]3([CH3:28])[O:27][C:2]4=[N:6][C:5]([N+:7]([O-:9])=[O:8])=[CH:4][N:3]4[CH2:10]3)[CH2:14][CH2:15]2)=[N:25][CH:24]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 60 °C
Procedure
The 1-(2-Bromo-4-nitro-imidazol-1-yl)-3-[4-(5-bromo-pyrimidin-2-yl)-[1,4]diazepan-1-yl]-2-methyl-propan-2-ol (600 mg, 1.15 mmol) in DMF (4 ml) was treated with NaH (33 mg, 1.4 mmol) at 0° C. and heated to 60° C. for 2 h. The reaction mixture is cooled, diluted with saturated NH4Cl (aq) and extracted with EtOAc. The organic layer was dried over Na2SO4, concentrated and purified by column chromatography to titled compound (384 mg, 75%). ESI MS m/z 439 (M+H+); 1H NMR (400 MHz, CDCl3) δ 8.24 (s, 2H), 7.4 (s, 1H) 4.15 (d, J=23 Hz, 1H), 3.81 (m, 5H), 3.06 (d, J=38 Hz, 1H), 2.95 (m, 2H), 2.85 (m, 1H), 2.75 (m, 1H), 2.62 (d, J=29 Hz, 1H), 1.63 (m, 2H), 1.54 (s, 3H).
Workup
- temperatureThe reaction mixture is cooled
- extractionextracted with EtOAc
- dry with materialThe organic layer was dried over Na2SO4
- concentrationconcentrated
- custompurified by column chromatography to titled compound (384 mg, 75%)
Sources & evidence
- ORD record
- ord-1947fed001f347ff8c89188f91e77657
- Source dataset
- uspto-grants-2010_02
- Patent number
- US07666864B2
Reaction notes
Loading…